ARWR
Arrowhead Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$71.65-3.57%
Price as of Jul 20, 2026
ARWR capital
Arrowhead Pharmaceuticals, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 2.24x
- Net debt / equity
- 1.93x
- Debt / assets
- 0.61x
- Debt / EBITDA
- -10.21x
- Net debt / EBITDA
- -8.81x
Liquidity & coverage
- Current ratio
- 6.23x
- Quick ratio
- 6.23x
- Cash ratio
- 6.04x
- Interest coverage
- -2.40x
- EBITDA / interest
- -1.45x
- Working capital
- $1.5B
Cash & dividend
- FCF / debt
- -0.04x
- Cash flow / debt
- -0.03x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.